Sandbox ID Eye: Difference between revisions

Jump to navigation Jump to search
Line 44: Line 44:


:*'''Empiric Therapy'''
:*'''Empiric Therapy'''
::*'''Anterior and Posterior blepharitis'''
::*'''Anterior blepharitis'''
:::*Preferred regimen: [[Bacitracin]] {{or}} [[Erythromycin]] topical/systemic  once or more times daily or  at bedtime for few weeks {{or}} Anti-inflammatory drugs such as [[Corticosteroids]], [[Cyclosporine]]
:::*Preferred regimen: [[Bacitracin]] {{or}} [[Erythromycin]] topical/systemic  once or more times daily or  at bedtime for few weeks {{or}} Anti-inflammatory drugs such as [[Corticosteroids]], [[Cyclosporine]]
:::*Alternate regimen: [[Metronidazole]] gel {{or}} [[Tobramycin]] {{or}} [[Dexamethasone]] ophthalmic suspension and [[Azithromycin]] sustained release system.
:::*Alternative regimen: [[Metronidazole]] gel {{or}} [[Tobramycin]] {{or}} [[Dexamethasone]] ophthalmic suspension and [[Azithromycin]] sustained release system.
::*'''Posterior blephatitis'''
::*'''Posterior blephatitis'''
:::* [[Cyclosporin]] topical  drops 0.05%
:::* [[Cyclosporin]] topical  drops 0.05%
Line 52: Line 52:


:*'''Specific considerations'''
:*'''Specific considerations'''
::*'''Mebomian Gland Dysfunction''' :
::*'''Mebomian gland dysfunction''' :
:::*Preferred regimen: [[Doxycycline]] {{or}} [[Minocycline]] 100mg daily tapered to [[Doxycycline]] {{or}} [[Minocycline]] 40-50mg daily after clinical improvement is noted ususally 2-6 weeks
:::*Preferred regimen: [[Doxycycline]] {{or}} [[Minocycline]] 100 mg daily tapered to [[Doxycycline]] {{or}} [[Minocycline]] 40-50mg daily after clinical improvement is noted ususally 2-6 weeks
:::*Alternate regimen: [[Erythromycin]] 250-500mg PO qd {{or}} [[Azithromycin]] 250-500mg 1-3 times a week or 1g per week for 3 weeks.
:::*Alternative regimen: [[Erythromycin]] 250-500 mg PO qd {{or}} [[Azithromycin]] 250-500mg 1-3 times a week or 1g per week for 3 weeks.
::::Note: [[Tetracyclines]] are contraindicated in pregnancy, nursing women and those with history of hypersenstivity to [[Tetracycline]]
::::Note (1): [[Tetracyclines]] are contraindicated in pregnancy, nursing women and those with history of hypersenstivity to [[Tetracycline]]
::::Note (2): Patients with contact-lens-associated giant papillary conjunctivitis have an increased frequency of mebomian gland dysfunction.
::*'''Dry eye'''
::*'''Dry eye'''
:::*Preferred regimen: [[Cyclosporin]] topical and [[Omega-3 Fatty acids]] two 1000 mg capsules tid per day
:::*Preferred regimen: [[Cyclosporin]] topical and Omega-3 fatty acids two 1000 mg capsules tid per day
::::Note: Diet modification is helpful.
::::Note: Diet modification is helpful.
::*'''Deramtological conditions with [[seborrhiec blepharitis]] and [[Mebomian Gland Dysfunction]]'''
::*'''Deramtological conditions with seborrhiec blepharitis and mebomian gland dysfunction'''
:::*Preferred regimen: [[Azithromycin]] oral with [[Tacrolimus]] 0.1% topical
:::*Preferred regimen: [[Azithromycin]] oral with [[Tacrolimus]] 0.1% topical
:::*Alternate regimen: [[Tetracycline]] oral
:::*Alternative regimen: [[Tetracycline]] oral
::::Note: In some patients [[Azithromycin]] oral may lead to abnormalities in electrical activity of heart with the potential to create serious irregularities in heart rhythm
::::Note: In some patients [[Azithromycin]] oral may lead to abnormalities in electrical activity of heart with the potential to create serious irregularities in heart rhythm
::*'''Demodicosis'''
::*'''Demodicosis'''
:::Preferred regimen: [[Metronidazole]] gel to eyelid skin
:::Preferred regimen: [[Metronidazole]] gel to eyelid skin
:::Alternate regimen: [[Ivermectin]] oral in recalcitrant [[Demodex]]
:::Alternative regimen: [[Ivermectin]] oral in recalcitrant Demodex bleharitis
::*'''Ocular Rosacea'''
::*'''Ocular Rosacea'''
:::*Preferred regimen: [[Tetracyclines]] topical
:::*Preferred regimen: [[Tetracyclines]] topical
::::Note: 1) patients with [[chronic blepharitis]] those doesnot respond to therapy the possibility of carcinoma should be considered particularly with associated loss of eyelashes.
::::Note (1): In patients with chronic blepharitis that does not respond to therapy, the possibility of carcinoma should be considered, particularly if associated with a loss of eyelashes.
::::::2) [[Isotretinoin]] used to treat [[cystic acne]] is associated with significant increase in colonization of conjunctiva with [[Staphylococcus aureus]] blepharitis and disruption of trear function. so its discontinuation leads to significant improvement.
::::Note (2): [[Isotretinoin]] used to treat cystic acne is associated with significant increase in colonization of conjunctiva with [[Staphylococcus aureus]] blepharitis and disruption of trear function. Discontinuation of isotretinoin leads to improvement in most cases.
::::::3) [[Gaint Papillary Conjunctivitis]] caused by using contact lense have increased frequency of [[Mebomian Gland Dysfunction]]


===Endophthalmitis, bacterial===
===Endophthalmitis, bacterial===

Revision as of 16:04, 3 June 2015

Conjunctivitis

  • Conjunctivitis, acute[1]
  • Bacterial conjunctivitis
  • Empiric antimicrobial therapy,
Note: Topical steroids are not recommended for bacterial conjunctivitis.
  • Pathogen-directed antimicrobial therapy
  • Chlamydia trachomatis
  • Inclusion conjunctivitis
  • Conjunctivitis secondary to trachoma
  • Neisseria gonorrhoeae
  • Hyperacute bacterial conjunctivitis, adult
Note: Dual therapy to cover Chlamydia is indicated.
  • Staphylococcus aureus, methicillin-resistant (MRSA)
  • Herpetic conjunctivitis
  • Herpes simplex virus
  • Preferred regimen: Acyclovir 1 drop topical 9 times per day OR Acyclovir 400 mg PO 5 times per day for 7-10 days OR Valacyclovir 500 mg PO tid for 7-10 days
Note: Topical steroids should be avoided.
  • Varicella zoster virus
Note: Treatment usually consists of a combination of oral antivirals and topical steroids.

Blepharitis

  • Empiric Therapy
  • Anterior blepharitis
  • Posterior blephatitis
Note: cure is usually not possible with blepharitis.Eyelid hygiene provide symptomatic relief for those with both anterior and posterior blepharitis.
  • Specific considerations
  • Mebomian gland dysfunction :
Note (1): Tetracyclines are contraindicated in pregnancy, nursing women and those with history of hypersenstivity to Tetracycline
Note (2): Patients with contact-lens-associated giant papillary conjunctivitis have an increased frequency of mebomian gland dysfunction.
  • Dry eye
  • Preferred regimen: Cyclosporin topical and Omega-3 fatty acids two 1000 mg capsules tid per day
Note: Diet modification is helpful.
  • Deramtological conditions with seborrhiec blepharitis and mebomian gland dysfunction
Note: In some patients Azithromycin oral may lead to abnormalities in electrical activity of heart with the potential to create serious irregularities in heart rhythm
  • Demodicosis
Preferred regimen: Metronidazole gel to eyelid skin
Alternative regimen: Ivermectin oral in recalcitrant Demodex bleharitis
  • Ocular Rosacea
Note (1): In patients with chronic blepharitis that does not respond to therapy, the possibility of carcinoma should be considered, particularly if associated with a loss of eyelashes.
Note (2): Isotretinoin used to treat cystic acne is associated with significant increase in colonization of conjunctiva with Staphylococcus aureus blepharitis and disruption of trear function. Discontinuation of isotretinoin leads to improvement in most cases.

Endophthalmitis, bacterial

Endophthalmitis, bleb-related

Endophthalmitis, candidal

Endophthalmitis, chronic

Endophthalmitis, mold

Endophthalmitis, post-cataract surgery, acute

Endophthalmitis, post-cataract surgery, chronic

Endophthalmitis, post-tramatic

Keratitis, bacterial

Keratitis, fungal

Keratitis, protozoal

Keratitis, viral

Ocular syphilis

Ocular toxocariasis

Ocular toxoplasmosis

Ocular tuberculosis

Orbital cellulitis

Periocular Infection

Retinal necrosis, acute, CMV

Retinal necrosis, acute, HSV or VZV

Retinal necrosis, progressive outer, VZV

Retinitis, CMV

Stye

Uveitis, acute anterior

Uveitis, Lyme disease

References

  1. Azari, Amir A.; Barney, Neal P. (2013-10-23). "Conjunctivitis: a systematic review of diagnosis and treatment". JAMA. 310 (16): 1721–1729. doi:10.1001/jama.2013.280318. ISSN 1538-3598. PMC 4049531. PMID 24150468.